Growth Metrics

Precision Biosciences (DTIL) Other Non-Current Assets (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Other Non-Current Assets for 8 consecutive years, with $26.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Non-Current Assets rose 16.5% to $26.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $26.3 million, a 16.5% increase, with the full-year FY2024 number at $22.6 million, up 9930.67% from a year prior.
  • Other Non-Current Assets was $26.3 million for Q3 2025 at Precision Biosciences, up from $208000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $26.3 million in Q3 2025 to a low of $208000.0 in Q2 2025.
  • A 5-year average of $8.1 million and a median of $4.4 million in 2021 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: crashed 98.18% in 2023, then skyrocketed 9930.67% in 2024.
  • Precision Biosciences' Other Non-Current Assets stood at $4.6 million in 2021, then skyrocketed by 166.02% to $12.3 million in 2022, then plummeted by 98.18% to $225000.0 in 2023, then surged by 9930.67% to $22.6 million in 2024, then increased by 16.53% to $26.3 million in 2025.
  • Per Business Quant, the three most recent readings for DTIL's Other Non-Current Assets are $26.3 million (Q3 2025), $208000.0 (Q2 2025), and $22.6 million (Q1 2025).